Protagonist Therapeutics Inc (PTGX)
30.74
-1.20
(-3.76%)
USD |
NASDAQ |
May 17, 16:00
30.74
0.00 (0.00%)
After-Hours: 20:00
Protagonist Therapeutics Shares Outstanding: 58.65M for April 30, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
April 30, 2024 | 58.65M |
April 24, 2024 | 58.64M |
March 31, 2024 | 58.60M |
March 15, 2024 | 58.57M |
February 22, 2024 | 58.28M |
December 31, 2023 | 57.71M |
October 27, 2023 | 57.68M |
September 30, 2023 | 57.65M |
July 31, 2023 | 57.53M |
June 30, 2023 | 57.49M |
April 28, 2023 | 57.25M |
April 10, 2023 | 57.19M |
March 31, 2023 | 51.44M |
March 15, 2023 | 51.42M |
March 02, 2023 | 51.28M |
December 31, 2022 | 49.34M |
October 31, 2022 | 49.20M |
September 30, 2022 | 49.20M |
July 28, 2022 | 49.08M |
June 30, 2022 | 48.68M |
April 29, 2022 | 48.66M |
March 31, 2022 | 48.55M |
March 15, 2022 | 48.55M |
February 15, 2022 | 48.41M |
December 31, 2021 | 47.84M |
Date | Value |
---|---|
October 29, 2021 | 47.73M |
September 30, 2021 | 47.67M |
July 30, 2021 | 47.55M |
June 30, 2021 | 47.53M |
June 18, 2021 | 47.45M |
April 30, 2021 | 43.95M |
March 31, 2021 | 43.94M |
March 15, 2021 | 43.92M |
February 26, 2021 | 43.81M |
December 31, 2020 | 43.75M |
December 15, 2020 | 43.73M |
October 30, 2020 | 38.26M |
September 30, 2020 | 37.31M |
July 31, 2020 | 36.81M |
June 30, 2020 | 36.80M |
May 14, 2020 | 36.72M |
May 11, 2020 | 28.67M |
March 31, 2020 | 27.43M |
March 13, 2020 | 27.42M |
February 28, 2020 | 27.29M |
December 31, 2019 | 27.22M |
October 31, 2019 | 27.21M |
September 30, 2019 | 27.21M |
July 31, 2019 | 26.28M |
June 30, 2019 | 24.97M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
24.97M
Minimum
Jun 30 2019
58.65M
Maximum
Apr 30 2024
45.35M
Average
47.78M
Median
Shares Outstanding Benchmarks
Lifecore Biomedical Inc | 30.55M |
SELLAS Life Sciences Group Inc | 57.75M |
Akebia Therapeutics Inc | 209.60M |
Immuneering Corp | 29.65M |
Moderna Inc | 383.24M |